1Markus HS.Barley J.Lunt R.et al.Angiotension-converting enzyme gene deletion polymorphism:a new risk factor for lacunar stroke but not carotid stheroms[ J] .Stroke, 1995,26:1329-1333.
2Margaglione M.Celentsno E.Grandone E.et al.Deletion polymorphysom in the angiotension-converting enzyme gene in patients with a history of ischemic stroke[J].Arterioscler Thromb Vase Biol, 1996.16:304-309.
4Roggas JJ.Moczulski D.Freire M.et al.Diabetic nephropathy is assocated with AGT polymorphism T235:results of a flmily-based study[J].Hypertension.1998.31:627-631.
5Barley J.Markus H.Brown M,et al.Lack of association between angiotensingogen polymorphism(M235T)and cerebrovasculadr disdease and carotid atheroma[J].J Hum Hypertens.1995.9:681- 683.
6Pedro-Boter J.Senti M.Nogues X.et al.Lipoprotein and apolipoprotein profile in men with ischemia stroke:role of lipoprotein(a),triglyceriderich lipoproteins and apolipoprotein E polymorphism[J].Stroke 23 : 1556-1562.
7Couderc R.Mahieux F.Balilleul S.et al.Prevalence of apolipoprotein E phyenotypes in ischemic cerebrovascular disease.A case-control study [J]. Stroke, 1993,25 : 2296-2297.
8Selhub J.D'Angelo A.Relationship between homocycteine and thrombotic disease[J].Am J Med Sci, 1990,316:129-141.
9Hiramoto M.Voshida H,Imaizumi T.et al,A mutatin in plasma platelet activating factor acetylhydrolase is a gene risk factor for stroke[J].Stroke.1997.28:2417-2420.
10Kalimo H.Vitanen M.Amberla K.et al.CADSIL:heraditary disease of arteries causing brain in farcts and demenlia[J].Neuropathol Appl Neurobiol.1999.25:257-265.
